Overview of RAW264.7 for Osteoclastogensis Study: Phenotype and Stimuli

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2019 Mar 21

PMID 30892789

Citations 58

Authors

Lingbo Kong

Wanli Smith

Dingjun Hao

Affiliations

Soon will be listed here.

Abstract

Bone homeostasis is preserved by the balance of maintaining between the activity of osteogenesis and osteoclastogenesis. However, investigations for the osteoclastogenesis were hampered by considerable difficulties associated with isolating and culturing osteoclast in vivo. As the alternative, stimuli-induced osteoclasts formation from RAW264.7 cells (RAW-OCs) have gain its importance for extensively osteoclastogenic study of bone diseases, such as rheumatoid arthritis, osteoporosis, osteolysis and periodontitis. However, considering the RAW-OCs have not yet been well-characterized and RAW264.7 cells are polymorphic because of a diverse phenotype of the individual cells comprising this cell linage, and different fate associated with various stimuli contributions. Thus, in present study, we provide an overview for current knowledge of the phenotype of RAW264.7 cells, as well as the current understanding of the complicated interactions between various stimuli and RAW-OCs in the light of the recent progress.

Citing Articles

Targeting dipeptidyl peptidase-8/9 to combat inflammation-induced osteoclastogenesis in RAW264.7 macrophages and analysis of anti-osteoclastogenesis potential of chrysin.

Ahmad S, Ahmed F, Ahmad S, Krishnan A, Ahmed Khan M Iran J Basic Med Sci. 2025; 28(4):516-526.

PMID: 39968082 PMC: 11831742. DOI: 10.22038/ijbms.2025.82219.17784.

Protective effects of Catalpol to attenuate TNF- α and collagen-induced inflammation in vitro HFLS-RA cells and in vivo mice models for the treatment of rheumatoid arthritis.

Wu B, Dong Q, Zhang Q, Jin F, Weng J Clin Rheumatol. 2025; 44(3):1041-1056.

PMID: 39907970 DOI: 10.1007/s10067-024-07261-3.

Dual release scaffolds as a promising strategy for enhancing bone regeneration: an updated review.

Zhang Y, Zhou C, Xie Q, Xia L, Liu L, Bao W Nanomedicine (Lond). 2025; 20(4):371-388.

PMID: 39891431 PMC: 11812394. DOI: 10.1080/17435889.2025.2457317.

Eupalinolide B inhibits periodontitis development by targeting ubiquitin conjugating enzyme UBE2D3.

Kuang W, Zhuge R, Song P, Yi L, Zhang S, Zhang Y MedComm (2020). 2025; 6(1):e70034.

PMID: 39811801 PMC: 11731104. DOI: 10.1002/mco2.70034.

Exploring the Effects of Zingerone on Differentiation and Signalling Pathways in Bone Cell Lines.

De Vos B, Kasonga A, Joubert A, Nyakudya T Metabolites. 2024; 14(12).

PMID: 39728474 PMC: 11676073. DOI: 10.3390/metabo14120693.

References

Mizutani H, Ishihara Y, Izawa A, Fujihara Y, Kobayashi S, Gotou H . Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice. J Periodontal Res. 2013; 48(6):748-56. DOI: 10.1111/jre.12065. View

Shi X, Chen L, Li S, Sun X, Cui F, Ma H . The observed difference of RAW264.7 macrophage phenotype on mineralized collagen and hydroxyapatite. Biomed Mater. 2018; 13(4):041001. DOI: 10.1088/1748-605X/aab523. View

Chu E, Brimer P, Jacobson K, Merriam E . Mammalian cell genetics. I. Selection and characterization of mutations auxotrophic for L-glutamine or resistant to 8-azaguanine in Chinese hamster cells in vitro. Genetics. 1969; 62(2):359-77. PMC: 1212281. DOI: 10.1093/genetics/62.2.359. View

Pang X, Bian H, Su M, Ren Y, Qi J, Ma H . Photoelectrochemical Cytosensing of RAW264.7 Macrophage Cells Based on a TiO Nanoneedls@MoO Array. Anal Chem. 2017; 89(15):7950-7957. DOI: 10.1021/acs.analchem.7b01038. View

Wu A, He Y, Broomfield A, Paatan N, Harrington B, Tseng H . CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer. J Pathol. 2016; 239(2):218-30. DOI: 10.1002/path.4718. View

Galvin R, Gatlin C, Horn J, Fuson T . TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. Biochem Biophys Res Commun. 1999; 265(1):233-9. DOI: 10.1006/bbrc.1999.1632. View

Hughes C, Finney B, Koentgen F, Lowe K, Watson S . The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets. Blood. 2014; 125(1):144-54. PMC: 4281823. DOI: 10.1182/blood-2014-05-579375. View

Reinke D, Kogawa M, Barratt K, Morris H, Anderson P, Atkins G . Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice. J Steroid Biochem Mol Biol. 2015; 164:353-360. DOI: 10.1016/j.jsbmb.2015.11.015. View

Wilson S, Mohan R, Netto M, Perez V, Possin D, Huang J . RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing. Invest Ophthalmol Vis Sci. 2004; 45(7):2201-11. DOI: 10.1167/iovs.03-1162. View

10.

Collin-Osdoby P, Osdoby P . RANKL-mediated osteoclast formation from murine RAW 264.7 cells. Methods Mol Biol. 2011; 816:187-202. DOI: 10.1007/978-1-61779-415-5_13. View

11.

Fata J, Kong Y, Li J, Sasaki T, Irie-Sasaki J, Moorehead R . The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell. 2000; 103(1):41-50. DOI: 10.1016/s0092-8674(00)00103-3. View

12.

Yang J, Zhu Y, Duan D, Wang P, Xin Y, Bai L . Enhanced activity of macrophage M1/M2 phenotypes in periodontitis. Arch Oral Biol. 2017; 96:234-242. DOI: 10.1016/j.archoralbio.2017.03.006. View

13.

Quinn J, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N . Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res. 2001; 16(10):1787-94. DOI: 10.1359/jbmr.2001.16.10.1787. View

14.

Suda K, Woo J, Takami M, Sexton P, Nagai K . Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J Cell Physiol. 2002; 190(1):101-8. DOI: 10.1002/jcp.10041. View

15.

Izawa T, Zou W, Chappel J, Ashley J, Feng X, Teitelbaum S . c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton. Mol Cell Biol. 2012; 32(14):2943-53. PMC: 3416198. DOI: 10.1128/MCB.00077-12. View

16.

Kong Y, Boyle W, Penninger J . Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. Immunol Cell Biol. 1999; 77(2):188-93. DOI: 10.1046/j.1440-1711.1999.00815.x. View

17.

Kong Y, Yoshida H, Sarosi I, Tan H, Timms E, Capparelli C . OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999; 397(6717):315-23. DOI: 10.1038/16852. View

18.

Blair H, Athanasou N . Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol. 2004; 19(1):189-99. DOI: 10.14670/HH-19.189. View

19.

Worth L, Cochran B, Haddox M . Phosphorylation of ornithine decarboxylase at both serine and threonine residues in the ODC-overproducing, Abelson virus-transformed RAW264 cell line. Cancer Res. 1994; 54(15):3967-70. View

20.

Faccio R, Zou W, Colaianni G, Teitelbaum S, Ross F . High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype. J Cell Biochem. 2003; 90(5):871-83. DOI: 10.1002/jcb.10694. View